Home/Filings/4/A/0000950170-24-013362
4/A//SEC Filing

SCHADE CHRISTIAN S 4/A

Accession 0000950170-24-013362

CIK 0001850838other

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 5:00 PM ET

Size

5.6 KB

Accession

0000950170-24-013362

Insider Transaction Report

Form 4/AAmended
Period: 2023-07-10
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-07-10+36,71336,713 total
    Exercise: $4.69Exp: 2033-07-09Common Stock (36,713 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable in thirty-six substantially equal monthly installments following the date of grant, such that the option shall be fully vested and exercisable on the third anniversary of the date of grant, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such vesting date.

Documents

1 file

Issuer

Omega Therapeutics, Inc.

CIK 0001850838

Entity typeother

Related Parties

1
  • filerCIK 0001214496

Filing Metadata

Form type
4/A
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 5:00 PM ET
Size
5.6 KB